Literature DB >> 28242784

Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia.

Andrei V Krivtsov1, Takayuki Hoshii1, Scott A Armstrong1.   

Abstract

Recent studies have shown the importance of chromatin-modifying complexes in the maintenance of developmental gene expression and human disease. The mixed lineage leukemia gene (MLL1) encodes a chromatin-modifying protein and was discovered as a result of the cloning of translocations involved in human leukemias. MLL1 is a histone lysine 4 (H3K4) methyltransferase that supports transcription of genes that are important for normal development including homeotic (Hox) genes. MLL1 rearrangements result in expression of fusion proteins without H3K4 methylation activity but may gain the ability to recruit other chromatin-associated complexes such as the H3K79 methyltransferase DOT1L and the super elongation complex. Therefore, chromosomal translocations involving MLL1 appear to directly perturb the regulation of multiple chromatin-associated complexes to allow inappropriate expression of developmentally regulated genes and thus drive leukemia development.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28242784      PMCID: PMC5666623          DOI: 10.1101/cshperspect.a026658

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  87 in total

1.  MLL fusion partners AF4 and AF9 interact at subnuclear foci.

Authors:  F Erfurth; C S Hemenway; A C de Erkenez; P H Domer
Journal:  Leukemia       Date:  2004-01       Impact factor: 11.528

2.  A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

Authors:  Dorothee Mueller; Christian Bach; Deniz Zeisig; Maria-Paz Garcia-Cuellar; Sara Monroe; Arun Sreekumar; Rong Zhou; Alexey Nesvizhskii; Arul Chinnaiyan; Jay L Hess; Robert K Slany
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

3.  Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.

Authors:  Matthew G Guenther; Lee N Lawton; Tatiana Rozovskaia; Garrett M Frampton; Stuart S Levine; Thomas L Volkert; Carlo M Croce; Tatsuya Nakamura; Eli Canaani; Richard A Young
Journal:  Genes Dev       Date:  2008-12-15       Impact factor: 11.361

4.  BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Authors:  Jake E Delmore; Ghayas C Issa; Madeleine E Lemieux; Peter B Rahl; Junwei Shi; Hannah M Jacobs; Efstathios Kastritis; Timothy Gilpatrick; Ronald M Paranal; Jun Qi; Marta Chesi; Anna C Schinzel; Michael R McKeown; Timothy P Heffernan; Christopher R Vakoc; P Leif Bergsagel; Irene M Ghobrial; Paul G Richardson; Richard A Young; William C Hahn; Kenneth C Anderson; Andrew L Kung; James E Bradner; Constantine S Mitsiades
Journal:  Cell       Date:  2011-09-01       Impact factor: 41.582

Review 5.  Readers of histone modifications.

Authors:  Miyong Yun; Jun Wu; Jerry L Workman; Bing Li
Journal:  Cell Res       Date:  2011-03-22       Impact factor: 25.617

6.  hDOT1L links histone methylation to leukemogenesis.

Authors:  Yuki Okada; Qin Feng; Yihui Lin; Qi Jiang; Yaqiang Li; Vernon M Coffield; Lishan Su; Guoliang Xu; Yi Zhang
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

Review 7.  MLL translocations, histone modifications and leukaemia stem-cell development.

Authors:  Andrei V Krivtsov; Scott A Armstrong
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

8.  Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.

Authors:  Aniruddha J Deshpande; Liying Chen; Maurizio Fazio; Amit U Sinha; Kathrin M Bernt; Deepti Banka; Stuart Dias; Jenny Chang; Edward J Olhava; Scott R Daigle; Victoria M Richon; Roy M Pollock; Scott A Armstrong
Journal:  Blood       Date:  2013-01-29       Impact factor: 22.113

9.  Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice.

Authors:  H Yagi; K Deguchi; A Aono; Y Tani; T Kishimoto; T Komori
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

10.  Structural analysis of the KANSL1/WDR5/KANSL2 complex reveals that WDR5 is required for efficient assembly and chromatin targeting of the NSL complex.

Authors:  Jorge Dias; Nhuong Van Nguyen; Plamen Georgiev; Aline Gaub; Janine Brettschneider; Stephen Cusack; Jan Kadlec; Asifa Akhtar
Journal:  Genes Dev       Date:  2014-05-01       Impact factor: 11.361

View more
  25 in total

Review 1.  Challenges and Opportunities for Childhood Cancer Drug Development.

Authors:  Peter J Houghton; Raushan T Kurmasheva
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

2.  New Potent DOT1L Inhibitors for in Vivo Evaluation in Mouse.

Authors:  Frédéric Stauffer; Andreas Weiss; Clemens Scheufler; Henrik Möbitz; Christian Ragot; Kim S Beyer; Keith Calkins; Daniel Guthy; Michael Kiffe; Bernard Van Eerdenbrugh; Ralph Tiedt; Christoph Gaul
Journal:  ACS Med Chem Lett       Date:  2019-12-04       Impact factor: 4.345

Review 3.  COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer.

Authors:  Richard J Fagan; Andrew K Dingwall
Journal:  Cancer Lett       Date:  2019-05-22       Impact factor: 8.679

Review 4.  The Unexpected Noncatalytic Roles of Histone Modifiers in Development and Disease.

Authors:  Yann Aubert; Shaun Egolf; Brian C Capell
Journal:  Trends Genet       Date:  2019-07-10       Impact factor: 11.639

Review 5.  Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease.

Authors:  Kamakoti P Bhat; H Ümit Kaniskan; Jian Jin; Or Gozani
Journal:  Nat Rev Drug Discov       Date:  2021-01-19       Impact factor: 84.694

Review 6.  Oncohistones: Exposing the nuances and vulnerabilities of epigenetic regulation.

Authors:  Michelle M Mitchener; Tom W Muir
Journal:  Mol Cell       Date:  2022-08-18       Impact factor: 19.328

7.  A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML.

Authors:  Michael A Koldobskiy; Jordi Abante; Garrett Jenkinson; Elisabet Pujadas; Ashley Tetens; Feifei Zhao; Rakel Tryggvadottir; Adrian Idrizi; Andreas Reinisch; Ravindra Majeti; John Goutsias; Andrew P Feinberg
Journal:  Epigenetics       Date:  2020-02-29       Impact factor: 4.528

8.  A molecular study of synovial chondromatosis.

Authors:  Narasimhan P Agaram; Lei Zhang; Brendan C Dickson; David Swanson; Yun-Shao Sung; David M Panicek; Meera Hameed; John H Healey; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2019-10-18       Impact factor: 5.006

9.  A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.

Authors:  Andrei V Krivtsov; Kathryn Evans; Jayant Y Gadrey; Benjamin K Eschle; Charlie Hatton; Hannah J Uckelmann; Kenneth N Ross; Florian Perner; Sarah N Olsen; Tara Pritchard; Lisa McDermott; Connor D Jones; Duohui Jing; Ali Braytee; Diego Chacon; Eric Earley; Brian M McKeever; David Claremon; Andrew J Gifford; Heather J Lee; Beverly A Teicher; John E Pimanda; Dominik Beck; Jennifer A Perry; Malcolm A Smith; Gerard M McGeehan; Richard B Lock; Scott A Armstrong
Journal:  Cancer Cell       Date:  2019-12-09       Impact factor: 31.743

Review 10.  Epigenetic Basis of Cellular Senescence and Its Implications in Aging.

Authors:  Timothy Nacarelli; Pingyu Liu; Rugang Zhang
Journal:  Genes (Basel)       Date:  2017-11-24       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.